Search for: "Janssen Research " Results 21 - 40 of 203
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
31 Jan 2018, 10:31 am by Law Firm
Recent research also suggests that patients taking Invokana or Invokamet are twice as likely to undergo a lower limb amputation versus those with diabetes who are not taking these medications. [read post]
29 Jan 2018, 5:00 am by melissalafreniere
Janssen Research & Development, Case No. 2:17-cv-17835, in the U.S. [read post]
23 Jan 2018, 5:00 am by melissalafreniere
But, alleges the lawsuit, research shows that Xarelto is safer and more effective if taken twice a day and while patients are undergoing blood monitoring. [read post]
19 Jan 2018, 12:28 pm by Dr. Shezad Malik
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
19 Jan 2018, 12:28 pm by Dr. Shezad Malik
Johnson & Johnson and it’s Janssen subsidiary are exposed to allegations that the companies failed to adequately research the potential side effects of Invokana, and failed to warn about severe side effects from its blockbuster line of new diabetic drugs. [read post]
17 Jan 2018, 5:00 am by melissalafreniere
Janssen Research and Developments LLC, et al., Case No. 2:17-cv-17526, in the U.S. [read post]
16 Jan 2018, 5:00 am by melissalafreniere
Other experts in child psychiatry expressed concern over the discovery of alleged research misconduct on behalf of Janssen. [read post]
11 Jan 2018, 5:00 am by melissalafreniere
Drug manufacturers and distributors hit with opioid lawsuits include: Purdue Teva/Cephalon Janssen Endo Actavis Mallinckrodt McKesson Corporation AmerisourceBergen Corporation Cardinal Health Inc. [read post]
11 Jan 2018, 5:00 am by melissalafreniere
Janssen Research & Development LLC, et al., Case No. 2:17-cv-17468, in the U.S. [read post]
5 Jan 2018, 12:00 pm by Tom Lamb
Categories: SGLT-2 Inhibitors Diabetes Drugs Hepatitis C Treatment Drugs Anticoagulants / Bloodthinners Breast Implants Osteoporosis Treatment Drugs Erectile Dysfunction (ED) Drugs Heartburn / Acid Reflux Drugs Multiple Sclerosis (MS) Treatment Drugs DPP-4 Inhibitors Diabetes Drugs Miscellaneous   SGLT-2 Inhibitors Diabetes Drugs: Jardiance - Amputations Drug Safety Issue Remains Uncertain Due To Admitted "inherent limitations of... post hoc analyses" (11/28/17) Medical… [read post]
5 Jan 2018, 5:00 am by melissalafreniere
Johnson and Johnson’s Janssen Pharmaceuticals and Bayer Health Care market Xarelto and together they shared the news of the failed phase three study in a press release last October. [read post]
29 Dec 2017, 5:00 am by melissalafreniere
Janssen and Johnson & Johnson made billions off the drug and it is still prescribed currently. [read post]
21 Dec 2017, 5:00 am by melissalafreniere
Some research studies, however, show the dangers of improper monitoring of the patient, all of which can make a person more likely to suffer serious internal bleeding and a host of other side effects. [read post]
19 Dec 2017, 7:30 am by Law Firm
This drug is manufactured by Janssen Pharmaceuticals, which is a division of Johnson & Johnson. [read post]
19 Dec 2017, 5:00 am by melissalafreniere
Drug makers were hit with thousands of lawsuits alleging Risperdal caused gynecomastia and further research has discovered increased risk of that condition and others linked to the drug. [read post]
19 Dec 2017, 5:00 am by melissalafreniere
Drug makers were hit with thousands of lawsuits alleging Risperdal caused gynecomastia and further research has discovered increased risk of that condition and others linked to the drug. [read post]
18 Dec 2017, 12:11 pm by Jeff Rasansky
Pre-market research conducted by the Johnson & Johnson subsidiary Janssen revealed the tendency of the drug to cause gynecomastia, yet warnings on the drug’s labels greatly understate the potential risk of breast development in males who take the medication. [read post]
18 Dec 2017, 12:11 pm by Jeff Rasansky
Pre-market research conducted by the Johnson & Johnson subsidiary Janssen revealed the tendency of the drug to cause gynecomastia, yet warnings on the drug’s labels greatly understate the potential risk of breast development in males who take the medication. [read post]
15 Dec 2017, 5:00 am by melissalafreniere
The drug is manufactured and distributed by Janssen, Johnson & Johnson, and Bayer. [read post]
15 Dec 2017, 5:00 am by melissalafreniere
The drug is manufactured and distributed by Janssen, Johnson & Johnson, and Bayer. [read post]